Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Viral Vector Production (Research-use) market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Viral Vector Production (Research-use) market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Viral Vector Production (Research-use) market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Viral Vector Production (Research-use) products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Viral Vector Production (Research-use) products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Viral Vector Production (Research-use) market.
To learn more about this report
Increasing research and development spending on Viral Vector Production (Research-use) development has been the leading industry trend of Viral Vector Production (Research-use) market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Others |
| By Application Outlook | Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Cobra Biologics Ltd., Thermo Fisher Scientific, Waisman Biomanufacturing, Genezen, YPOSKESI, Advanced BioScience Laboratories, Inc. (ABL, Inc.), Novasep Holding S.A.S, Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.), Vigene Biosciences, Inc., General Electric Company (GE Healthcare), CEVEC Pharmaceuticals GmbH, Batavia Biosciences B.V., Biovion oy, Wuxi AppTec Co., Ltd., VGXI, Inc., Catalent Inc., Miltenyi Biotec GmbH, SIRION Biotech GmbH, Virovek Incorporation, BioNTech IMFS GmbH, VIVEbiotech S.L., Creative Biogene, Vibalogics GmbH, Takara Bio., Cell and Gene Therapy Catapult, BlueBird Bio, Addgene, Inc., Aldevron, L.L.C., Audentes Therapeutics, BioMarin Pharmaceutical, RegenxBio, Inc. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Viral Vector Production (Research-use) Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Viral Vector Production (Research-use) Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Viral Vector Production (Research-use) Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Viral Vector Production (Research-use) Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Adeno-associated virus (AAV)
4.2.2 Lentivirus
4.2.3 Adenovirus
4.2.4 Retrovirus
4.2.5 Others
4.4 Type Comparison Matrix
4.5 Global Viral Vector Production (Research-use) Market Attractiveness, By Type
5 Global Viral Vector Production (Research-use) Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Viral Vector Production (Research-use) Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Cell & Gene Therapy Development
5.3.2 Vaccine Development
5.3.3 Biopharmaceutical and Pharmaceutical Discovery
5.3.4 Biomedical Research
5.4 Application Comparison Matrix
5.5 Global Viral Vector Production (Research-use) Market Attractiveness, by Application
6 Global Viral Vector Production (Research-use) Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Viral Vector Production (Research-use) Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Viral Vector Production (Research-use) Market Attractiveness, by Region
8 North America Viral Vector Production (Research-use) Market Analysis and Forecast
8.1 Key Findings
8.2 North America Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Adeno-associated virus (AAV)
8.2.2 Lentivirus
8.2.3 Adenovirus
8.2.4 Retrovirus
8.2.5 Others
8.3 North America Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Cell & Gene Therapy Development
8.3.2 Vaccine Development
8.3.3 Biopharmaceutical and Pharmaceutical Discovery
8.3.4 Biomedical Research
8.4 North America Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Viral Vector Production (Research-use) Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Viral Vector Production (Research-use) Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Adeno-associated virus (AAV)
9.2.2 Lentivirus
9.2.3 Adenovirus
9.2.4 Retrovirus
9.2.5 Others
9.3 Europe Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Cell & Gene Therapy Development
9.3.2 Vaccine Development
9.3.3 Biopharmaceutical and Pharmaceutical Discovery
9.3.4 Biomedical Research
9.4 Europe Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Viral Vector Production (Research-use) Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Viral Vector Production (Research-use) Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Adeno-associated virus (AAV)
10.2.2 Lentivirus
10.2.3 Adenovirus
10.2.4 Retrovirus
10.2.5 Others
10.3 Asia Pacific Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Cell & Gene Therapy Development
10.3.2 Vaccine Development
10.3.3 Biopharmaceutical and Pharmaceutical Discovery
10.3.4 Biomedical Research
10.4 Asia Pacific Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Viral Vector Production (Research-use) Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Viral Vector Production (Research-use) Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Adeno-associated virus (AAV)
11.2.2 Lentivirus
11.2.3 Adenovirus
11.2.4 Retrovirus
11.2.5 Others
11.3 Latin America Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Cell & Gene Therapy Development
11.3.2 Vaccine Development
11.3.3 Biopharmaceutical and Pharmaceutical Discovery
11.3.4 Biomedical Research
11.4 Latin America Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Viral Vector Production (Research-use) Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Viral Vector Production (Research-use) Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Adeno-associated virus (AAV)
12.2.2 Lentivirus
12.2.3 Adenovirus
12.2.4 Retrovirus
12.2.5 Others
12.3 Middle East & Africa (MEA) Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Cell & Gene Therapy Development
12.3.2 Vaccine Development
12.3.3 Biopharmaceutical and Pharmaceutical Discovery
12.3.4 Biomedical Research
12.4 Middle East & Africa (MEA) Viral Vector Production (Research-use) Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Viral Vector Production (Research-use) Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Merck KGaA
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Lonza
13.3.3 FUJIFILM Diosynth Biotechnologies U.S.A.
13.3.4 Inc.
13.3.5 Cobra Biologics Ltd.
13.3.6 Thermo Fisher Scientific
13.3.7 Waisman Biomanufacturing
13.3.8 Genezen
13.3.9 YPOSKESI
13.3.10 Advanced BioScience Laboratories
13.3.11 Inc. (ABL
13.3.12 Inc.)
13.3.13 Novasep Holding S.A.S
13.3.14 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
13.3.15 Vigene Biosciences
13.3.16 Inc.
13.3.17 General Electric Company (GE Healthcare)
13.3.18 CEVEC Pharmaceuticals GmbH
13.3.19 Batavia Biosciences B.V.
13.3.20 Biovion oy
13.3.21 Wuxi AppTec Co.
13.3.22 Ltd.
13.3.23 VGXI
13.3.24 Inc.
13.3.25 Catalent Inc.
13.3.26 Miltenyi Biotec GmbH
13.3.27 SIRION Biotech GmbH
13.3.28 Virovek Incorporation
13.3.29 BioNTech IMFS GmbH
13.3.30 VIVEbiotech S.L.
13.3.31 Creative Biogene
13.3.32 Vibalogics GmbH
13.3.33 Takara Bio.
13.3.34 Cell and Gene Therapy Catapult
13.3.35 BlueBird Bio
13.3.36 Addgene
13.3.37 Inc.
13.3.38 Aldevron
13.3.39 L.L.C.
13.3.40 Audentes Therapeutics
13.3.41 BioMarin Pharmaceutical
13.3.42 RegenxBio
13.3.43 Inc.
14 Key Takeaways
Choose License Type